SLC6A3 and Parkinson disease: Hence, striatal dopamine transporter imaging is advantageous for determining the degree of impairment in dopamine neurons, which would correlate not only with the severity of motor symptoms in patients with PD (31) but also with cognitive deterioration during its clinical course (32).